Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy
Immune checkpoint inhibitors are used to restore or augment antitumor immune responses and show great promise in the treatment of melanoma and other types of cancers. However, only a small percentage of patients are fully responsive to immune checkpoint inhibition, mostly due to tumor heterogeneity...
Guardado en:
Autores principales: | Marisa Schmitt, Tobias Sinnberg, Heike Niessner, Andrea Forschner, Claus Garbe, Boris Macek, Nicolas C. Nalpas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91ad1cf1ba114fcb9bb863931ff9ce55 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An integrated workflow for enhanced taxonomic and functional coverage of the mouse fecal metaproteome
por: Nicolas Nalpas, et al.
Publicado: (2021) -
Proteogenomics analysis of CUG codon translation in the human pathogen Candida albicans
por: Stefanie Mühlhausen, et al.
Publicado: (2021) -
Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas
por: Wentao Fang, et al.
Publicado: (2021) -
Combination of Proteogenomics with Peptide <italic toggle="yes">De Novo</italic> Sequencing Identifies New Genes and Hidden Posttranscriptional Modifications
por: B. Blank-Landeshammer, et al.
Publicado: (2019) -
Primary urethral melanoma treated sucessfully with wide excision and combination immunotherapy: Case report and review of literature
por: Mariela Martinez, et al.
Publicado: (2022)